Celesio AG reported earnings results for the nine months ended December 31, 2015. For the period, the company reported revenue from continuing operations of 16,227.8 million, EBIT of 331.9 million, adjusted EBIT of 343.5 million, Profit before taxes of 293.7 million, adjusted profit before taxes of 305.2 million, net profit of 202.9 million or 0.99 per share, adjusted net profit of 212.7 million or 1.03 per share, against revenue of 15,196.1 million, EBIT of 257.6 million, adjusted EBIT of 318.5 million, Profit before taxes of 208.9 million, adjusted profit before taxes of 269.8 million, net profit of 128.6 million or 0.64 per share, adjusted net profit of 183.7 million or 0.92 per share, a year ago. The revenue gain of an exclusive distribution contract with a major manufacturer in the United Kingdom and the volume growth in the British pharmacies more than offset the loss in revenue due to the loss of the hospital contract in Norway.
Thereby overall positive exchange rate effects amounted to 489.6 million, mainly related to the British pound sterling. Net debt increased from 897.0 million as of 31 March 2015 to 1,023.2 million as of 31 December 2015. Net profit and loss from continuing and discontinued operations came to 189.6 million compared to a net profit of 36.7 million a year ago.
Accordingly, basic and diluted earnings per share came to 0.92 compared to 0.18 a year ago.